Delivery Order SPE2DB22D1106-SPE2DB24FDKX1
- Not listed
- This federal contract award, valued at $5,899.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of Doxepin HCL 3 mg tablets in 30-count packages. This is a firm fixed-price delivery order contract with a performance period through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- This federal contract award, valued at $3,442.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Doxepin HCL 6 mg tablets to support military and federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through...
- This federal contract award, with ID SPE2DX15D6038|SPE2DX24F1ZQ4, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,135.14 delivery order is for Doxepin HCl 3 mg tablets, with a completion date of November 17, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a Firm Fixed Price Delivery Order worth $7,131.37. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 22, 2023. The contract covers the delivery of Doxepin HCL 3mg Tablets in quantities of 30s, with a completion date of September 25, 2023. Amerisourcebergen is the prime contractor on this award and holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,963.49, is for the delivery of Doxepin HCL 3 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $4,389.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Doxepin Hydrochloride 3 mg tablets. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, identified as SPE2DB22D2007|SPE2DB24FJ1ZV, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of doxepin hydrochloride 3 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of April 30, 2024, and a ceiling value of $1,537.23. It is a Firm Fixed Price Delivery Order contract. The contract does not have a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,180.70, is for the delivery of 4,562,253,135 tablets of Doxepin Hydrochloride 3 mg. The contract has a completion date of September 21, 2023 and is a firm fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc.,...
- This federal contract award is for the delivery of Doxepin HCL 3 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,729.85, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of January 12, 2024. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,561.98 contract is for the delivery of Doxepin HCL 3 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDKX1Delivery Order
This federal contract award, valued at $7,535.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of 3 mg Doxepin HCl tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 7, 2023, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/6/23 |